0001209191-23-053691.txt : 20231026
0001209191-23-053691.hdr.sgml : 20231026
20231026173416
ACCESSION NUMBER: 0001209191-23-053691
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231024
FILED AS OF DATE: 20231026
DATE AS OF CHANGE: 20231026
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kulkarni Sandeep Chidambar
CENTRAL INDEX KEY: 0001945691
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40384
FILM NUMBER: 231351280
MAIL ADDRESS:
STREET 1: 92 MORNINGSIDE AVE.
STREET 2: APT 7E
CITY: NEW YORK
STATE: NM
ZIP: 10027
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tourmaline Bio, Inc.
CENTRAL INDEX KEY: 0001827506
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 27 WEST 24TH STREET
STREET 2: SUITE 702
CITY: NEW YORK
STATE: NY
ZIP: 10010
BUSINESS PHONE: 646-481-9832
MAIL ADDRESS:
STREET 1: 27 WEST 24TH STREET
STREET 2: SUITE 702
CITY: NEW YORK
STATE: NY
ZIP: 10010
FORMER COMPANY:
FORMER CONFORMED NAME: Talaris Therapeutics, Inc.
DATE OF NAME CHANGE: 20201007
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-10-24
0
0001827506
Tourmaline Bio, Inc.
TRML
0001945691
Kulkarni Sandeep Chidambar
C/O TOURMALINE BIO, INC.
27 WEST 24TH STREET, SUITE 702
NEW YORK
NY
10010
1
1
0
0
CEO
0
Common Stock
2023-10-24
4
P
0
4650
10.68
A
720735
D
Common Stock
2023-10-26
4
P
0
5000
12.25
A
725735
D
/s/ Brad Middlekauff, Attorney-in-Fact
2023-10-26